Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suzetrigine for Postoperative Pain in Minimally Invasive Hysterectomy
NCT07836010Phase 4Not yet recruiting
- Sponsor
- Duke University
- Start
- Nov 2026
- Primary completion
- Jan 2028
01
Overview
A Phase 4 trial of suzetrigine in postoperative pain, sponsored by Duke University. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
suzetrigine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07836010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07836010.